STAAR Surgical Company  

(Public, NASDAQ:STAA)   Watch this stock  
Find more results for Logan Todd�
6.86
-1.07 (-13.49%)
Feb 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.74 - 7.84
52 week 4.84 - 19.74
Open 7.73
Vol / Avg. 576,933.00/386,024.00
Mkt cap 301.90M
P/E     -
Div/yield     -
EPS -0.18
Shares 38.65M
Beta 0.44
Inst. own 78%
Apr 27, 2015
Q1 2015 STAAR Surgical Co Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 25, 2015
Q4 2014 STAAR Surgical Co Earnings Call - Webcast
Feb 25, 2015
Q4 2014 STAAR Surgical Co Earnings Release
Dec 2, 2014
STAAR Surgical Co at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '14) 2014
Net profit margin -14.88% 0.55%
Operating margin -8.54% 0.97%
EBITD margin - 3.95%
Return on average assets -17.07% 0.68%
Return on average equity -26.32% 1.13%
Employees 335 -
CDP Score - -

Address

1911 Walker Ave
MONROVIA, CA 91016
United States - Map
+1-626-3037902 (Phone)
+1-626-3032962 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

STAAR Surgical Company (STAAR) designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye. The Company makes lenses used in corrective or refractive surgery, and make lenses for use in surgery that treats cataracts. Activities outside the United States accounted for approximately 82% of its total sales in Fiscal 2013, due to the pacing of product approvals and commercialization that tend to occur outside the United States, STAAR sells its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain. STAAR has initiated a project to consolidate all of its manufacturing to its Monrovia, California facility. STAAR, Visian, Collamer, CentraFlow, AquaPort, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow are trademarks or registered trademarks of STAAR in the United States and other countries. Collamer is the brand name for STAAR�s proprietary collagen copolymer lens material.

Officers and directors

Mark B. Logan Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Stephen P. Brown Chief Financial Officer, Vice President
Age: 54
Bio & Compensation  - Reuters
Hans-Martin Blickensdoerfer President, Europe, Middle East, Africa, Latin America
Age: 49
Bio & Compensation  - Reuters
Donald J. Todd President, Asia Pacific
Age: 61
Bio & Compensation  - Reuters
Deborah J. Andrews Chief Accounting Officer, Vice President
Age: 56
Bio & Compensation  - Reuters
Paul Hambrick Vice President - Global Operations
Age: 51
Bio & Compensation  - Reuters
Philippe Subrin Vice President - Switzerland Operations
Age: 50
Bio & Compensation  - Reuters
Samuel J. Gesten Vice President, General Counsel, Corporate Compliance Officer and Secretary
Age: 52
Bio & Compensation  - Reuters
Robin Hughes Vice President - Global Research and Development, Regulatory and Quality
Age: 50
Bio & Compensation  - Reuters
Donald Lee Fagen Vice President - North American Sales
Age: 60
Bio & Compensation  - Reuters